Table 5.
Comparing incidences of toxic effects between the propensity score matched treatment group.
| Pemetrexed | Non- Pemetrexed | P | ||||
|---|---|---|---|---|---|---|
| 125 pairs | ||||||
| Adverse events | N | % | N | % | ||
| Fatigue | AE | 18 | 14.29% | 26 | 20.63% | 0.184 |
| SAE | 0 | 0 | 0 | 0 | — | |
| Fever | AE | 1 | 0.79% | 3 | 2.38% | 0.622 |
| SAE | 0 | 0 | 0 | 0 | — | |
| Nausea | AE | 102 | 81.60% | 99 | 79.20% | 0.633 |
| SAE | 1 | 0.79% | 6 | 4.76% | 0.12 | |
| Vomiting | AE | 64 | 50.79% | 34 | 26.98% | <0.001 |
| SAE | 0 | 0 | 4 | 3.17% | 0.122 | |
| Mucositis | AE | 2 | 1.59% | 4 | 3.17% | 0.684 |
| SAE | 0 | 0 | 0 | 0 | — | |
| Constipation | AE | 8 | 6.35% | 5 | 3.97% | 0.393 |
| SAE | 0 | 0 | 0 | 0 | — | |
| Rash | AE | 4 | 3.17% | 0 | 0.00% | 0.122 |
| SAE | 0 | 0 | 0 | 0 | — | |
| Alopecia | AE | 7 | 5.56% | 29 | 23.20% | <0.001 |
| SAE | 0 | 0 | 3 | 2.38% | 0.247 | |
| WBC | AE | 57 | 45.60% | 98 | 78.40% | <0.001 |
| SAE | 4 | 3.17% | 28 | 22.22% | <0.001 | |
| Neutropenia | AE | 69 | 55.20% | 95 | 76.00% | 0.001 |
| SAE | 14 | 11.11% | 56 | 44.44% | <0.001 | |
| Anemia | AE | 44 | 35.20% | 57 | 45.24% | 0.124 |
| SAE | 0 | 0 | 0 | 0 | — | |
| Thrombocytopenia | AE | 21 | 16.67% | 24 | 19.05% | 0.622 |
| SAE | 3 | 2.38% | 3 | 2.38% | 1 | |
AE, adverse event SAE, sever adverse event.